Skip to content

Novanta

US · NOVT #1995 by market cap Listed 1970
101.99 -12.89 -11.22%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
  • Total institutional ownership rose 4.0 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
127.71% +4.00pp
Institutions
473 -3
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund111.05%
Hedge Fund8.29%
Public Company4.13%
Government Pension Fund1.40%
Sovereign Wealth Fund1.23%
Individual/Insider0.71%
Private Company0.53%
Insurance Company0.49%
Family Office/Trust0.38%

Top holders as of 2026-09-30

BlackRock 15.07% · 5.70M sh
T. Rowe Price Group, Inc. 7.23% · 2.74M sh
Vanguard Portfolio Management, LLC 6.38% · 2.41M sh
Vanguard Capital Management, LLC 4.49% · 1.70M sh
Allspring Global Investments, LLC 4.35% · 1.64M sh
State Street Global Advisors 4.33% · 1.64M sh
Wasatch Advisors LP 2.78% · 1.05M sh
Conestoga Capital Advisors, LLC 3.22% · 1.22M sh
Geode Capital Management, LLC 2.72% · 1.03M sh
Congress Asset Management Company, LLP 2.59% · 979.84K sh
William Blair Investment Management, LLC 2.53% · 956.76K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 22 buys · 28 sells

NameRoleStake
Robert Buckley Chief Financial Officer 0.35%
Matthijs Glastra Chairperson & CEO 0.22%
Charles Ravetto Co-Chief Operating Officer of Automation Enabling Technologies 0.04%
John Burke Chief Accounting Officer 0.02%
Lonny Carpenter Lead Independent Director 0.02%
Maxine Mauricio Independent Director 0.01%
Frank Wilson Independent Director 0.01%
Darlene J. Solomon Independent Director 0.01%
Robert Johnson Independent Director 0.01%
John Lesica Co-Chief Operating Officer of Medical Solutions 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-02 Matthew Farrell Independent Director Derivative Exercise and Retained +241 --
2026-09-10 Thomas Secor Independent Director Automatic Disposition -663 $147.60
2026-07-01 Matthijs Glastra Chairperson & CEO Automatic Disposition -6,500 $160.13–164.20
2026-06-01 Matthijs Glastra Chairperson & CEO Automatic Disposition -6,500 $164.61–171.28
2026-06-01 Matthijs Glastra Chairperson & CEO Intent to Sell (Form 144) -6,500 --
2026-05-11 Matthijs Glastra Chairperson & CEO Automatic Disposition -7,500 $150.00–151.34
2026-05-04 Matthijs Glastra Chairperson & CEO Automatic Disposition -6,500 $130.59–133.27
2026-04-16 Matthijs Glastra Chairperson & CEO Automatic Disposition -6,500 $130.05
2026-03-15 Robert Buckley Chief Financial Officer Derivative Exercise and Sale -9,957 $14.13–118.80
2026-03-01 Matthijs Glastra Chairperson & CEO Automatic Disposition -6,500 $131.92–140.48
2026-02-23 Matthijs Glastra Chairperson & CEO Derivative Exercise and Sale -5,247 $137.44
2026-02-23 Matthijs Glastra Chairperson & CEO Derivative Exercise and Retained +5,605 --
2026-02-23 Robert Buckley Chief Financial Officer Derivative Exercise and Sale -2,624 $137.44
2026-02-23 Robert Buckley Chief Financial Officer Derivative Exercise and Retained +2,802 --
2026-02-23 Charles Ravetto Co-Chief Operating Officer of Automation Enabling Technologies Derivative Exercise and Sale -243 $137.44
2026-02-23 Charles Ravetto Co-Chief Operating Officer of Automation Enabling Technologies Derivative Exercise and Retained +582 --
2026-02-23 John Burke Chief Accounting Officer Derivative Exercise and Sale -141 $137.44
2026-02-23 John Burke Chief Accounting Officer Derivative Exercise and Retained +338 --
2026-02-22 Charles Ravetto Co-Chief Operating Officer of Automation Enabling Technologies Derivative Exercise and Sale -311 $142.38
2026-02-22 Charles Ravetto Co-Chief Operating Officer of Automation Enabling Technologies Derivative Exercise and Retained +748 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.

Novanta discussion 0 comments

Add a comment